Found 9 matching trials
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease N/A This study intends to select patients with confirmed moderate-to-severe Cro...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study N/A The primary aim of this study is to explore the time course of response to ...
Show More Status
Active Not Recruiting
Location
GI Alliance - Sun City
Learn More & Join Trial
Real-Life Evaluation of Guselkumab Dosing Interval Adjustments N/A "Guselkumab (Tremfya®) is a fully human monoclonal antibody that selectivel...
Show More Learn More & Join Trial
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients PHASE3 The trial is an open-label randomized study that will examine whether switc...
Show More Location
Family Arthritis Center
Learn More & Join Trial
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis N/A In a real-world setting, this study systematically evaluates the clinical e...
Show More Location
The Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) PHASE4 The purpose of this study is to evaluate how well guselkumab works in parti...
Show More Location
The First Affiliated Hospital Sun Yat sen University
Learn More & Join Trial
Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease N/A The goal of this observational registry study is to evaluate the real-world...
Show More Location
Caja Costarricense del Seguro Social
Learn More & Join Trial
Multi-Center PAMPA Study PHASE4 This is a multi-center (North-America), randomized, double-blind, placebo-c...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD) N/A Patients with refractory inflammatory bowel disease (IBD) show inadequate r...
Show More Location
Center of Inflammatory Bowel Disease, Department of Gastroenterology, the Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial